Daiichi Sankyo US

The Prix Galien awards are considered the pinnacle of scientific advancement in medicine. To be recognized by The Galien Foundation with the 2024 Prix Galien USA award for Best Biotechnology Product for our HER2 directed ADC is a testament of our endless pursuit to develop life-changing solutions for the patients of today and tomorrow. It is truly remarkable to witness how innovations from this class of nominees, as well as those from previous years, have profoundly influenced the treatment landscape. We extend this recognition to the entire oncology community, united by our unwavering desire to help create practice-changing medicines. Above all, we share this with the patients we serve today, tomorrow, always.

??We are thrilled to announce that Daiichi Sankyo US has been honored as a BioSpace 2025 Best Place to Work! This recognition reflects our unwavering dedication to fostering an inclusive and empowering environment where innovation—and our people—can thrive. ? From mentoring to resource groups and other great initiatives, Daiichi Sankyo is committed to helping our employees bring their best selves to work and nurturing their unique craft so that we can collectively deliver on our mission to help patients. ? ?? Discover more about our company culture: https://lnkd.in/eB8wu_dQ ? ??Interested in opportunities with us: https://lnkd.in/gjF4AFHC ? #BestPlacestoWork #DSProud #HealthcareInnovation #JoinUs

Biomarker testing has a vital role in the treatment of cancer. It ensures the right medicine reaches the right patient at the right time, embodying the hope of precision medicine.?? ? It's crucial for patients, caregivers and healthcare teams to prioritize biomarker testing at diagnosis.?? ? Amy C. Moore, PhD shares why she’s empowering patients to Talk, Test, Treat. Learn more about biomarker testing below: https://bit.ly/4hXXqXE ? #LungCancerAwarenessMonth #LCAM

By forging pathways to learn from one another and embrace diversity, we strengthen our ability to innovate—bringing light beyond our office to patients around the globe. ? ? A celebration of light over darkness, #Diwali brings people together to embrace connection, joy, and belonging. At our office event this fall, colleagues including Pallavi Patil, helped bring the festival of lights to life.? ? “By sharing my culture, I can help break down stereotypes, build bridges of new connections, and help others appreciate diversity. Education and awareness are essential components of inclusivity and belonging.”? ? Click for more on Life at Daiichi Sankyo: https://lnkd.in/eczSwS_s ? ? #DSProud #Inclusion?

Data Update: At the Connective Tissue Oncology Society 2024 Annual Meeting Daiichi Sankyo US will share new clinical research in certain patients with symptomatic tenosynovial giant cell tumor (#TGCT).? ? Click the image to learn more about our presence at #CTOS2024.?

Explore the legacy of the The Galien Foundation Prix Galien awards and discover what it means for Daiichi Sankyo US to win the 2024 Prix Galien USA award for Best Biotechnology Product for our HER2 directed ADC. Learn more in our latest Our Stories article: https://bit.ly/4fHubGC

Today we honor the leadership, dedication, and diverse experiences that U.S. veterans bring to the workforce.? ? For Air Force veteran and Senior District Manager, Oncology, Eric Chancellor, harnessing his unique background and skillset helps his team succeed. When we embrace the diversity of our workforce, we build a stronger, more innovative team—one that drives meaningful impact for the patients we serve.? ? ?? Want to learn more about how we champion veterans in the workplace? Meet with Daiichi Sankyo US on November 26th during the national virtual Recruit Military Career Fair for Veterans: https://lnkd.in/eEfaxv_M ? “For me, elevating the multi-faceted perspectives of military life can foster deeper understanding and create richer connections. Embracing those different mindsets and perspectives allows us to do better by the people we serve.”? ? Thank you, Eric, and veterans everywhere for your service!? #DSProud #VeteransDay

Interested in a career in the pharmaceutical industry? ?? Connect with us on the upcoming VIRTUAL RecruitMilitary Career Fair for Veterans on November 26 and learn about opportunities at Daiichi Sankyo US. #Hiring #RecruitMilitary

Science ?? Technology ?? Engineering ? Math ?? = STEM. ? Today we celebrate all STEM advocates and professionals, from the students just learning and fellows in training, to the scientists behind the scenes and the healthcare professionals on the front lines, who are making a difference in the lives of patients. ? ?? Comment below with “Why you decided to pursue a career in the sciences?” ? ? Swipe for responses from our innovators of tomorrow, our fellows Sara Blodgett, PharmD, RPh, Matthew Armanus, PharmD, MBA, RPh, and Juhi Hegde, PharmD, RPh ? #InternationalSTEMDay #DSProud

#BreakingNews: Two of our DXd ADCs have been recognized as the “Most Promising Clinical Candidate” by World ADC. Based on the proprietary Daiichi Sankyo US DXd ADC Technology, these ADCs reflect our dedication to innovation and demonstrates how we are making substantial progress toward our goal of creating standards of care for patients with difficult-to-treat cancers. Thank you to World ADC for elevating scientific achievement in the ADC space.